Internal Medicine, Gastroenterology · Goshen, NY
NPI
1184622672
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
70 Hatfield Ln, Ste 204
Goshen, NY, 10924
Phone (845) 291-1260
Groups this clinician bills Medicare through
Medicare paid, 2024
$380K
3,233 services
Medicare patients, 2024
1,230
Average age 73
Drug cost, 2024
$2.3M
2,861 prescriptions
Company payments, 2025
$4,866
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lance M Siegel was code 99213 (office e&m - established), 670 times for 543 patients. In total Lance M Siegel billed 3,233 services in 78 codes, and Medicare paid $380K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 670 | 543 | $68.52 | $46K |
| 99214 Office E&M - Established | Office | 437 | 341 | $102.72 | $45K |
| 43239 Upper GI Endoscopy | Office | 248 | 236 | $308.08 | $76K |
| 45380 Lower GI Endoscopy - Other | Office | 217 | 217 | $216.47 | $47K |
| 99232 Hospital E&M - Subsequent | Facility | 193 | 112 | $63.85 | $12K |
| 99203 Office E&M - New | Office | 180 | 180 | $82.53 | $15K |
| 43239 Upper GI Endoscopy | Facility | 177 | 169 | $83.96 | $15K |
| 45385 Colonoscopy - Lesion Removal | Office | 139 | 138 | $380.52 | $53K |
| 82948 Clinical Chemistry | Office | 108 | 86 | $4.94 | $534 |
| 45380 Lower GI Endoscopy - Other | Facility | 97 | 97 | $63.91 | $6,199 |
| 45385 Colonoscopy - Lesion Removal | Facility | 77 | 77 | $204.60 | $16K |
| 99222 Hospital E&M - Initial | Facility | 74 | 72 | $103.70 | $7,674 |
| 36415 Venipuncture Blood Collection | Office | 68 | 51 | $8.65 | $588 |
| 43249 Upper GI Endoscopy | Facility | 44 | 42 | $121.63 | $5,352 |
| 99204 Office E&M - New | Office | 43 | 43 | $134.18 | $5,770 |
By year: 2022 $386K for 3,302 services; 2023 $354K for 3,078 services; 2024 $380K for 3,233 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82948 Clinical Chemistry | 108 | 86 | $4.94 | $534 |
| 36415 Venipuncture Blood Collection | 68 | 51 | $8.65 | $588 |
| 85025 Blood Count | 37 | 30 | $7.61 | $282 |
| 80053 Clinical Chemistry | 28 | 23 | $10.35 | $290 |
| 82728 Clinical Chemistry | 22 | 20 | $13.36 | $294 |
| 83540 Clinical Chemistry | 21 | 19 | $6.34 | $133 |
| 83550 Clinical Chemistry | 19 | 17 | $8.57 | $163 |
| 82607 Clinical Chemistry | 17 | 16 | $14.78 | $251 |
| 82248 Clinical Chemistry | 16 | 15 | $4.92 | $78.72 |
| 82746 Clinical Chemistry | 15 | 15 | $14.41 | $216 |
Medicare prescription drug claims, 2024
In 2024, the drug Lance M Siegel prescribed most often to Medicare patients was Pantoprazole Sodium, with 639 prescriptions and refills. In total Lance M Siegel wrote 2,861 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 639 | 1,732 | 255 | $11K |
| Famotidine Generic | 372 | 1,003 | 149 | $8,431 |
| Omeprazole Generic | 227 | 576 | 92 | $3,977 |
| Creon Lipase/Protease/Amylase | 132 | 241 | 47 | $357K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 132 | 132 | 131 | $8,394 |
| Zenpep Lipase/Protease/Amylase | 102 | 179 | 27 | $333K |
| Esomeprazole Magnesium Generic | 73 | 203 | 28 | $3,755 |
| Linzess Linaclotide | 69 | 167 | 27 | $87K |
| Dexlansoprazole Dr Dexlansoprazole | 61 | 153 | 18 | $34K |
| Mesalamine Generic | 55 | 108 | 15 | $53K |
| Sucralfate Generic | 48 | 92 | 23 | $8,092 |
| Mesalamine Er Mesalamine | 46 | 90 | 18 | $16K |
| Dicyclomine Hcl Generic | 45 | 78 | 15 | $1,391 |
| Rabeprazole Sodium Generic | 43 | 112 | 13 | $1,890 |
| Lansoprazole Generic | 40 | 86 | 13 | $1,282 |
Brand drugs: 619 claims; generic drugs: 2,242 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lance M Siegel $4,866 ($4,866 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $1,325.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 54 | $1,325 |
| Janssen Biotech, Inc. JNJ | 21 | $1,012 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $416 |
| QOL Medical, LLC | 6 | $367 |
| Madrigal Pharmaceuticals MDGL | 9 | $268 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $255 |
| Aimmune Therapeutics, Inc. | 5 | $202 |
| Genzyme Corporation SNY | 7 | $199 |
| Ardelyx, Inc. ARDX | 9 | $146 |
| Pfizer Inc. PFE | 12 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.